Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.21.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2021
Dec. 31, 2020
Current assets    
Cash and cash equivalents $ 274,992 $ 233,351
Accounts receivable, net 26,193 23,928
Inventory 14,315 1,404
Other receivables - related party 842 744
Prepaid expenses and other current assets 4,003 6,723
Total current assets 320,345 266,150
Property and equipment, net 13,126 11,923
Operating lease right-of-use asset, net 19,731 20,487
Restricted cash 1,645 1,645
Long-term investment, at fair value 48,484 17,566
Intangible asset, net 13,701 14,629
Other assets 1,126 1,013
Total assets 418,158 333,413
Current liabilities    
Accounts payable and accrued expenses 59,906 45,389
Deferred revenue 4,800 0
Operating lease liabilities, short-term 2,035 1,849
Partner company installment payments - licenses, short-term (net of imputed interest of $639 and $778 at June 30, 2021 and December 31, 2020, respectively) 3,861 4,522
Total current liabilities 70,602 51,760
Notes payable, long-term (net of debt discount of $7,737 and $8,323 at June 30, 2021 and December 31, 2020, respectively) 52,263 51,677
Operating lease liabilities, long-term 21,906 22,891
Partner company installment payments - licenses, long-term (net of imputed interest of $565 and $863 at June 30, 2021 and December 31, 2020, respectively) 6,435 8,137
Partner company convertible preferred shares (net of debt discount of $1,824 at June 30, 2021) 12,508 0
Partner company derivative warrant liabilities 4,287 0
Other long-term liabilities 1,856 1,949
Total liabilities 169,857 136,414
Commitments and contingencies
Stockholders' equity    
Cumulative redeemable perpetual preferred stock, $.001 par value, 15,000,000 authorized, 5,000,000 designated Series A shares, 3,427,138 shares issued and outstanding as of June 30, 2021 and December 31, 2020, respectively, liquidation value of $25.00 per share 3 3
Common stock, $.001 par value, 170,000,000 shares authorized, 97,495,244 shares issued and outstanding as of June 30, 2021; 150,000,000 shares authorized, 94,877,492 shares issued and outstanding as of December 31, 2021, respectively 97 95
Common stock issuable, 78,671 and 0 shares as of June 30, 2021 and December 31, 2020, respectively 263 0
Additional paid-in-capital 603,035 583,000
Accumulated deficit (495,117) (482,760)
Total stockholders' equity attributed to the Company 108,281 100,338
Non-controlling interests 140,020 96,661
Total stockholders' equity 248,301 196,999
Total liabilities and stockholders' equity $ 418,158 $ 333,413